Skip to main content
Clinical Trials/NCT02576743
NCT02576743
Completed
Not Applicable

Pushing Spatiotemporal Limits for 4D Flow MRI and Dynamic MRA in the Brain at Ultra-High Field

University of Minnesota1 site in 1 country90 target enrollmentNovember 2015
ConditionsStroke

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stroke
Sponsor
University of Minnesota
Enrollment
90
Locations
1
Primary Endpoint
Brain Flow Dynamics
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

This study aims at investigating the blood hemodynamics with high spatiotemporal resolution in patients with brain aneurysms and AVMs as well as in healthy controls. Parameters such as peak blood velocity, wall shear stress and other derived parameters will be obtained from 4D flow MRI data acquired at ultra-high field strength (7 Tesla).

Detailed Description

The hemodynamic factors responsible for hemorrhagic stroke, resulting in wide variations in the clinical management of underlying vascular lesions, especially when they are found in asymptomatic individuals or individuals with symptoms not related to the disease. Therefore, there is an urgent need for the development of reliable biomarkers based on hemodynamic parameters, which can then enable improvements in risk assessment in patients presenting with these lesions. This need can be met by non-invasive Magnetic Resonance Imaging (MRI) techniques that provide information on high resolution vascular anatomy, visualization of cerebral hemodynamics and quantitative information about blood velocity. However, such techniques as presently employed at 1.5 or 3 Tesla are limited by spatial resolution and prolonged data acquisition times. The primary goal of this proposal is to overcome these current limitations by exploiting Ultra-High Fields (UHF, i.e. ≥ 7 Tesla (7T)) to attain significantly higher spatial resolution, faster acquisitions and increased lesion conspicuity utilizing * Qualitative exploration of intracranial blood hemodynamics, * Quantitative imaging of the spatiotemporally resolved blood velocity vector, * Derivation of hemodynamic parameters.

Registry
clinicaltrials.gov
Start Date
November 2015
End Date
September 1, 2019
Last Updated
6 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Subjects / Patients between 18 and 75

Exclusion Criteria

  • Any kind of ferromagnetic implants.
  • MR-unsafe non-ferromagnetic implants.
  • Cardiac pacemakers.
  • A history of shrapnel or shot gun injury.
  • A body mass index \>
  • Severe claustrophobia.
  • Tattoos in the head/neck area or permanent makeup.

Outcomes

Primary Outcomes

Brain Flow Dynamics

Time Frame: 2 years

Altered brain flow hemodynamics in patients with aneurysms and AVMs compared to normal subjects

Study Sites (1)

Loading locations...

Similar Trials